Bizily Scott
Insider CIK 1920738 · FDMT Chief Legal and HR Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-10-16 | 2026-10-20 | 1,635 | — | $0 | 56,431 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-10-16 | 2026-10-20 | 1,635 | $12.84 | $21.0K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-10-16 | 2026-10-20 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-09-16 | 2026-09-22 | 1,635 | — | $0 | 58,066 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-16 | 2026-09-22 | 1,635 | $13.65 | $22.3K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-09-16 | 2026-09-22 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-09-16 | 2026-09-22 | 1,635 | — | $0 | 58,066 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-16 | 2026-09-22 | 1,635 | $13.65 | $22.3K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-09-16 | 2026-09-22 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-09-01 | 2026-09-03 | 584 | — | $0 | 2,959 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-09-01 | 2026-09-03 | 584 | $6.49 | $3.8K | 9,201 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-01 | 2026-09-03 | 584 | $14.00 | $8.2K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-09-01 | 2026-09-03 | 584 | — | $0 | 2,959 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-09-01 | 2026-09-03 | 584 | $14.00 | $8.2K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-09-01 | 2026-09-03 | 584 | $6.49 | $3.8K | 9,201 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-17 | 2026-08-17 | 1,635 | — | $0 | 59,701 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-17 | 2026-08-17 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-17 | 2026-08-17 | 1,635 | $12.20 | $19.9K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-17 | 2026-08-17 | 1,635 | — | $0 | 59,701 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-17 | 2026-08-17 | 1,635 | $12.20 | $19.9K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-17 | 2026-08-17 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-13 | 2026-08-17 | 1,635 | — | $0 | 61,336 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-13 | 2026-08-17 | 1,635 | $12.00 | $19.6K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-13 | 2026-08-17 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-08-13 | 2026-08-17 | 1,635 | — | $0 | 61,336 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-08-13 | 2026-08-17 | 1,635 | $12.00 | $19.6K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-08-13 | 2026-08-17 | 1,635 | $4.14 | $6.8K | 10,252 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-06-30 | 2026-07-02 | 814 | — | $0 | 62,971 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-06-30 | 2026-07-02 | 5,752 | — | $0 | 3,543 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-06-30 | 2026-07-02 | 6,566 | $14.00 | $91.9K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-06-30 | 2026-07-02 | 814 | $4.14 | $3.4K | 9,431 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-06-30 | 2026-07-02 | 5,752 | $6.49 | $37.3K | 15,183 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2026-06-23 | 2026-06-25 | 9,810 | — | $0 | 63,785 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2026-06-23 | 2026-06-25 | 9,810 | $4.14 | $40.6K | 18,427 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2026-06-23 | 2026-06-25 | 9,810 | $12.00 | $117.7K | 8,617 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-03-25 | 2026-03-27 | 217,000 | — | $0 | 217,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2025-12-16 | 2025-12-19 | 1,635 | — | $0 | 73,595 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-12-16 | 2025-12-19 | 1,635 | $10.90 | $17.8K | 3,594 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2025-12-16 | 2025-12-19 | 1,635 | $4.14 | $6.8K | 5,229 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 1,635 | — | $0 | 75,230 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-11-17 | 2025-11-19 | 1,635 | $10.59 | $17.3K | 3,594 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2025-11-17 | 2025-11-19 | 1,635 | $4.14 | $6.8K | 5,229 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2025-10-24 | 2025-10-27 | 1,084 | — | $0 | 9,295 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-10-24 | 2025-10-27 | 2,678 | $12.00 | $32.1K | 3,594 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2025-10-24 | 2025-10-27 | 1,084 | $6.49 | $7.0K | 6,272 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2025-10-16 | 2025-10-20 | 1,635 | — | $0 | 76,865 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-10-16 | 2025-10-20 | 1,635 | $10.17 | $16.6K | 5,188 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2025-10-16 | 2025-10-20 | 1,635 | $4.14 | $6.8K | 6,823 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-10-09 | 2025-10-14 | 2,408 | $10.00 | $24.1K | 5,188 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2025-09-23 | 2025-09-26 | 2,407 | $8.00 | $19.3K | 7,596 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-03-06 | 2025-03-10 | 78,500 | — | $0 | 78,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-09-16 | 2024-09-18 | 500 | — | $0 | 10,379 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-09-16 | 2024-09-18 | 500 | $6.49 | $3.2K | 7,281 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-09-16 | 2024-09-18 | 500 | $16.33 | $8.2K | 6,781 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-08-19 | 2024-08-21 | 500 | — | $0 | 10,879 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-08-19 | 2024-08-21 | 500 | $15.00 | $7.5K | 6,781 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-08-19 | 2024-08-21 | 500 | $6.49 | $3.2K | 7,281 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-16 | 2024-07-18 | 500 | — | $0 | 11,379 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-16 | 2024-07-18 | 1,250 | — | $0 | 32,502 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-16 | 2024-07-18 | 500 | $6.49 | $3.2K | 7,281 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-16 | 2024-07-18 | 1,250 | $8.04 | $10.0K | 8,531 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-07-16 | 2024-07-18 | 1,750 | $27.11 | $47.4K | 6,781 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-11 | 2024-07-15 | 1,996 | — | $0 | 23,004 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-11 | 2024-07-15 | 1,996 | $15.78 | $31.5K | 8,777 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-07-11 | 2024-07-15 | 1,996 | $25.00 | $49.9K | 6,781 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-01 | 2024-07-03 | 2,916 | — | $0 | 33,752 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-07-01 | 2024-07-03 | 1,332 | — | $0 | 11,879 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-01 | 2024-07-03 | 2,916 | $8.04 | $23.4K | 5,985 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-07-01 | 2024-07-03 | 4,248 | $21.36 | $90.7K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-07-01 | 2024-07-03 | 1,332 | $6.49 | $8.6K | 3,069 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-06-17 | 2024-06-20 | 1,250 | — | $0 | 36,668 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-06-17 | 2024-06-20 | 500 | — | $0 | 13,211 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-06-17 | 2024-06-20 | 1,250 | $8.04 | $10.0K | 3,487 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-06-17 | 2024-06-20 | 500 | $6.49 | $3.2K | 2,237 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-06-17 | 2024-06-20 | 1,750 | $23.71 | $41.5K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-05-16 | 2024-05-20 | 500 | — | $0 | 13,711 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-05-16 | 2024-05-20 | 1,250 | — | $0 | 37,918 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-05-16 | 2024-05-20 | 467 | $25.75 | $12.0K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-05-16 | 2024-05-20 | 500 | $6.49 | $3.2K | 2,237 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-05-16 | 2024-05-20 | 1,250 | $8.04 | $10.0K | 3,487 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-05-16 | 2024-05-20 | 1,283 | $25.34 | $32.5K | 2,204 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-16 | 2024-04-18 | 500 | — | $0 | 14,211 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-16 | 2024-04-18 | 1,250 | — | $0 | 39,168 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-04-16 | 2024-04-18 | 1,750 | $25.74 | $45.0K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-16 | 2024-04-18 | 1,250 | $8.04 | $10.0K | 3,487 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-16 | 2024-04-18 | 500 | $6.49 | $3.2K | 2,237 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,909 | — | $0 | 46,182 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 2,916 | — | $0 | 40,418 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,996 | — | $0 | 21,008 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,332 | — | $0 | 14,711 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-01 | 2024-04-03 | 1,996 | $15.78 | $31.5K | 7,981 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-04-01 | 2024-04-03 | 8,153 | $31.78 | $259.1K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-01 | 2024-04-03 | 1,332 | $6.49 | $8.6K | 3,069 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-01 | 2024-04-03 | 1,909 | $20.24 | $38.6K | 9,890 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-04-01 | 2024-04-03 | 2,916 | $8.04 | $23.4K | 5,985 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-03-27 | 2024-03-29 | 4,342 | — | $0 | 55,658 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-03-27 | 2024-03-29 | 1,491 | — | $0 | 54,167 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-03-27 | 2024-03-29 | 1,491 | $25.98 | $38.7K | 7,570 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-03-27 | 2024-03-29 | 4,342 | $25.98 | $112.8K | 6,079 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-03-27 | 2024-03-29 | 5,833 | $35.04 | $204.4K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-03-18 | 2024-03-20 | 1,250 | — | $0 | 43,334 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-03-18 | 2024-03-20 | 500 | — | $0 | 16,043 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-03-18 | 2024-03-20 | 500 | $6.49 | $3.2K | 2,237 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-03-18 | 2024-03-20 | 1,750 | $31.27 | $54.7K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-03-18 | 2024-03-20 | 1,250 | $8.04 | $10.0K | 3,487 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-27 | 2024-02-29 | 1,909 | — | $0 | 48,091 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-27 | 2024-02-29 | 1,909 | $30.00 | $57.3K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-27 | 2024-02-29 | 1,909 | $20.24 | $38.6K | 3,646 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-16 | 2024-02-21 | 1,250 | — | $0 | 44,584 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-16 | 2024-02-21 | 500 | — | $0 | 16,543 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-16 | 2024-02-21 | 1,250 | $8.04 | $10.0K | 3,487 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-16 | 2024-02-21 | 1,750 | $27.67 | $48.4K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-16 | 2024-02-21 | 500 | $6.49 | $3.2K | 2,237 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-08 | 2024-02-12 | 1,996 | — | $0 | 23,004 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-08 | 2024-02-12 | 2,916 | — | $0 | 45,834 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2024-02-08 | 2024-02-12 | 1,332 | — | $0 | 17,043 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-08 | 2024-02-12 | 1,332 | $27.50 | $36.6K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-08 | 2024-02-12 | 1,332 | $6.49 | $8.6K | 3,069 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-08 | 2024-02-12 | 2,916 | $8.04 | $23.4K | 4,653 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-08 | 2024-02-12 | 2,916 | $27.50 | $80.2K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2024-02-08 | 2024-02-12 | 1,996 | $15.78 | $31.5K | 3,733 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2024-02-08 | 2024-02-12 | 1,996 | $27.50 | $54.9K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-12-11 | 2023-12-13 | 130,000 | — | $0 | 130,000 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | M Exercise deriv | 2023-06-08 | 2023-06-12 | 3,750 | — | $0 | 48,750 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | M Exercise | 2023-06-08 | 2023-06-12 | 3,750 | $8.04 | $30.1K | 5,487 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | S Sale | 2023-06-08 | 2023-06-12 | 3,750 | $20.85 | $78.2K | 1,737 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | M Exercise deriv | 2023-06-01 | 2023-06-06 | 1,875 | — | $0 | 18,375 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | M Exercise | 2023-06-01 | 2023-06-06 | 1,875 | $6.49 | $12.2K | 3,984 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | S Sale | 2023-06-01 | 2023-06-06 | 2,247 | $18.31 | $41.1K | 1,737 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2023-04-21 | 2023-04-25 | 3,750 | — | $0 | 52,500 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2023-04-21 | 2023-04-25 | 3,750 | $8.04 | $30.1K | 5,859 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-04-21 | 2023-04-25 | 3,750 | $20.00 | $75.0K | 2,109 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2023-03-01 | 2023-03-03 | 1,875 | — | $0 | 20,250 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2023-03-01 | 2023-03-03 | 2,248 | $19.30 | $43.4K | 2,109 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2023-03-01 | 2023-03-03 | 1,875 | $6.49 | $12.2K | 4,357 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2023-02-10 | 2023-02-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2022-12-01 | 2022-12-05 | 3,750 | — | $0 | 56,250 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise deriv | 2022-12-01 | 2022-12-05 | 1,875 | — | $0 | 22,125 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 400 | $21.52 | $8.6K | 4,332 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2022-12-01 | 2022-12-05 | 1,875 | $6.49 | $12.2K | 4,732 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 975 | $22.71 | $22.1K | 3,357 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 400 | $23.25 | $9.3K | 2,957 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 100 | $24.49 | $2.4K | 2,857 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | M Exercise | 2022-12-01 | 2022-12-05 | 3,750 | $8.04 | $30.1K | 6,607 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 1,000 | $21.78 | $21.8K | 5,607 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 2,450 | $22.93 | $56.2K | 3,157 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 200 | $23.44 | $4.7K | 2,957 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 100 | $24.49 | $2.4K | 2,857 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | S Sale | 2022-12-01 | 2022-12-05 | 375 | $24.35 | $9.1K | 2,482 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-09-01 | 2022-09-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-06-18 | 2022-06-21 | 24,000 | — | $0 | 24,000 | SEC↗ |